Cause of death, by non-communicable diseases, ages 15-59, male in Senegal
Senegal: Cause of death, by non-communicable diseases, ages 15-59, male was 42.1% in 2021. ▲ Rising
Cause of death, by non-communicable diseases, ages 15-59, male in Senegal, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total male deaths ages 15-59.
Analysis
Senegal recorded 42.1% for cause of death, by non-communicable diseases, ages 15-59, male in 2021.
Compared with earlier readings it is down 9.8% on the previous year and down 4.5% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 15-59, male in Senegal peaked at 49.1% in 2019 and was at its lowest, 41.4%, in 2000.
That places Senegal 123rd out of 185 countries with data for 2021, putting it in the middle of the range.
Cause of death, by non-communicable diseases, ages 15-59, male in Senegal, year by year
| Year | % of total male deaths ages 15-59 | Change |
|---|---|---|
| 2000 | 41.4% | — |
| 2010 | 44.1% | +6.7% |
| 2015 | 46.7% | +5.9% |
| 2019 | 49.1% | +5.1% |
| 2020 | 46.7% | -4.9% |
| 2021 | 42.1% | -9.8% |
Senegal compared with similar countries
- Senegal's 42.1% is below the median for lower middle income countries, which is 42.5%, 99% of the median. (47 countries reporting)
- Senegal's 42.1% is above the median for Sub-Saharan Africa, which is 37.9%, 1.1× the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 41.4% | 41.4% | 41.4% | 1 |
| 2010s | 46.7% | 44.1% | 49.1% | 3 |
| 2020s | 44.4% | 42.1% | 46.7% | 2 |
Countries ranked near Senegal
More health data for Senegal
- Un projection of annual infant deaths, annual growth rate -1.58 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.7598 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 835.5 deaths per 1,000 people (2090)
- Number of infants who die before age 1 2,496 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 3 (2025)
- Population ages 00-04, female, annual growth rate 2.42 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0658 units per person (2025)
- Population ages 00-04, male, annual growth rate 1.29 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 15-59, male in Senegal?
- Cause of death, by non-communicable diseases, ages 15-59, male in Senegal was 42.1% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 15-59, male recorded in Senegal?
- The highest recorded value was 49.1% in 2019.
- What is the lowest cause of death, by non-communicable diseases, ages 15-59, male recorded in Senegal?
- The lowest recorded value was 41.4% in 2000.
- How does Senegal rank for cause of death, by non-communicable diseases, ages 15-59, male?
- Senegal ranks 123rd out of 185 countries with data for 2021.
- Is cause of death, by non-communicable diseases, ages 15-59, male rising or falling in Senegal?
- Over the last ten years it is down 4.5%. The long-run trend across the full record is rising.
- Where does this Senegal data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 15-59, male (% of total male deaths ages 15-59). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of male deaths ages 15-59 due to non-communicable diseases divided by number of all male deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.